Skip to content

Clinical trials

Completed Schizophrenia trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Mexico Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20041
20051
20062
20071
20085
20091
20102
20113
20124
20133
20152
20162
20172
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
Otsuka Pharmaceutical Development & Commercialization, Inc.5
FORUM Pharmaceuticals Inc3
Hoffmann-La Roche3
Janssen Research & Development, LLC3
Boehringer Ingelheim2
Denovo Biopharma LLC2
H. Lundbeck A/S2
Sumitomo Pharma America, Inc.2
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia35
Psychotic Disorders6
Bipolar Disorder3
Cognition Disorders3
Autistic Disorder1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.